On February 29, 2012, iBio, Inc., a pharmaceutical company, announced the issuance of a patent on an influenza virus vaccine. As a result, iBio’s stock increased over 10% during a time when the overall market was declining – proving, yet again, that intangible assets influence marginal value (or at least investor emotion and sentiment). This announcement and subsequent rise in iBio’s stock value is particularly interesting considering Fraunhofer USA, Inc. was, at least at the time, listed as the patent’s inventor and assignee.
ShareThis